Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
56,066,823
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
10,800,557
-
Shares change
-
+2,646,919
-
Total reported value, excl. options
-
$52,059,801
-
Value change
-
+$12,731,917
-
Put/Call ratio
-
109%
-
Number of buys
-
37
-
Number of sells
-
22
-
Price
-
$4.82
Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) as of Q3 2023
As of 30 Sep 2023 ZEVRA THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (ZVRA) had 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,800,557 shares of stock of the company.
Largest 10 holders included Nantahala Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Janney Montgomery Scott LLC, STATE STREET CORP, Retirement Planning Co of New England, Inc., NORTHERN TRUST CORP, Mystic Asset Management, Inc., and Bank of New York Mellon Corp.
This table shows 89 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.